Gluconeogenesis from pyruvate, alanine, lactate and propionate was inhibited by methylmalonate in both rat and guinea-pig hepatocytes. The effect was dose-dependent. Gluconeogenesis from glycerol and xylitol was not affected.
Methylmalonic acid accumulates in tissues and blood of patients with methylmalonyl-CoA mutase deficiency and vitamin B12 deficiency (for reviews see Rosenberg, 1972; Rosenberg & Scriver, 1974) . Metabolic ketoacidosis and hypoglycaemia are usual features of the disease methylmalonic aciduria, which results from the inability to metabolize methylmalonyl-CoA further (Rosenberg, 1972) . Because methylmalonyl-CoA inhibits pyruvate carboxylase, a key enzyme in the gluconeogenic pathway, it has been suggested that the hypoglycaemia might result from a derangement in gluconeogenesis (Utter, 1970) . In a study of propionate metabolism in vitamin B12-deficient rats, Weidemann et al. (1970) found that methylmalonate inhibited gluconeogenesis from propionate. The effect cannot be attributed to inhibition of pyruvate carboxylase, since the conversion of propionate to glucose does not involve this enzyme. Studies with isolated rat liver mitochondria have shown that methylmalonic acid is a potent inhibitor of the dicarboxylate carrier system of the inner mitochondrial membrane . It also inhibits tricarboxylic acid exchange on the tricarboxylate transporter as well as the malate/ phosphate exchange. On the basis of these studies, Halperin et al. (1971) hypothesized that methylmalonic acid might inhibit gluconeogenesis by interfering with the transport of metabolites across the mitochondrial membrane. The present study was undertaken to determine the effect of methylmalonate on glucose synthesis from a variety of substrates in isolated hepatocytes.
Materials and Methods

Chemicals and animals
Methylmalonic acid was purchased from Calbiochem., Los Angeles, CA, U.S.A. The sources of all other chemicals were given previously (Arinze & Rowley, 1975 
Isolation of hepatocytes and incubation
The preparation of hepatocytes and incubation conditions were as described previously (Arinze & Rowley, 1975) . Methylmalonic acid was dissolved in Krebs-Ringer bicarbonate buffer (Umbreit et al., 1964) , and the solution was adjusted to pH 7.4 before addition to the incubation medium. Glucose was measured enzymically by the method of Slein (1965) .
Results and Discussion Table 1 shows the effect of methylmalonate on gluconeogenesis from a variety of substrates in guinea-pig hepatocytes. At a concentration of 5mM, methylmalonate significantly inhibited gluconeogenesis from lactate and pyruvate. At higher concentrations of methylmalonate, glucose synthesis from alanine and propionate was also inhibited. In general, gluconeogenesis from all four substrates was inhibited by about 30 and 45-60% at methylmalonate concentrations of 10 and 20mM respectively. Gluconeogenesis from glycerol and xylitol was not affected at all concentrations of methylmalonate tested. Table 2 shows that gluconeogenesis from pyruvate, lactate and alanine was also inhibited in rat hepatocytes by methylmalonate. The extent of inhibition was approximately the same in the two species, except that, with lactate as substrate, the effect was somewhat greater in rat than in guinea-pig hepatocytes. The difference, although small, may be related to the location of phosphoenolpyruvate carboxykinase (Hanson & Garber, 1972) 
417±21 295 + 26** 236+ 27*** (Arinze et al., 1973) . In hepatocytes prepared from both species glucose production from glycerol was not affected by additions of methylmalonate. Since glucose production from glycerol and xylitol, which enter the gluconeogenic pathway above the level of triose phosphates, was not affected, the data in Tables I and 2 suggest that the site of inhibition in the gluconeogenic pathway lies below the level of the trioses. The effect observed is clearly dose-dependent. Halperin et al. (1971) have shown that methylmalonate interferes with di-and tricarboxylate exchange systems across the mitochondrial membrane, as well as with the malate/ phosphate exchange. The latter effect is similar to the inhibition of malate transport in mitochondria by n-butylmalonate (Robinson & Chappell, 1967) , which is known to inhibit gluconeogenesis from pyruvate (Williamson et al., 1970) . By analogy, pentylmalonate, another malonate derivative that affects transport across the mitochondrial membrane (Robinson et al., 1971) . The lowest concentration (2.5mM) of methylmalonate tested inhibited gluconeogenesis from pyruvate and alanine in guinea-pig liver cells by about 20%, but had a much greater effect on metabolite transport in mitochondria. In the studies of Weidemann et al. (1970) with rat kidney-cortex slices gluconeogenesis from propionate was inhibited by about 25% by 5 mM-methylmalonate. The concentration of methylmalonate (5-10mM) that significantly inhibits gluconeogenesis in isolated hepatocytes or kidneycortex slices is higher than the observed plasma concentrations (up to 3mM) of methylmalonate in cases of methylmalonic aciduria (Oberholzer et al., 1967; Morrow et al., 1969; Rosenberg, 1972) . However, in the present study and that of Weidemann et al. (1970) the uptake of methylmalonate from the incubation medium was not determined. There are only a few studies (see Morrow et al., 1969 ) that directly assess the hepatic or renal concentrations of methylmalonate in this disease. Such studies are necessary to establish whether the hypoglycaemia associated with the disease is causally related to a possible inhibition of gluconeogenesis in vivo by methylmalonate. 1979 
